Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Bristol-Myers Squibb
(NY:
BMY
)
58.94
+1.55 (+2.70%)
Official Closing Price
Updated: 4:10 PM EDT, Mar 25, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
9,041,848
Open
57.79
Bid (Size)
58.30 (100)
Ask (Size)
59.37 (800)
Prev. Close
57.39
Today's Range
57.79 - 59.39
52wk Range
42.52 - 62.89
Shares Outstanding
2,222,113,553
Dividend Yield
4.28%
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Why Bristol-Myers Squibb (BMY) Stock Is Up Today
Today 16:00 EDT
What Happened? Shares of biopharmaceutical company Bristol Myers Squibb (NYSE:BMY) jumped 2.6% in the afternoon session after its positive momentum continued...
Via
StockStory
Topics
Artificial Intelligence
Merck & Co. (MRK) 2026 Analysis: Navigating the Keytruda Cliff with Pipeline-Driven Resilience
Today 9:35 EDT
As of March 25, 2026, Merck & Co., Inc. (NYSE: MRK) stands at a pivotal crossroads in its 135-year history. Known globally as a titan of oncology and vaccines, the Rahway, New Jersey-based...
Via
Finterra
Topics
Artificial Intelligence
Economy
Intellectual Property
Performance
YTD
+10.3%
+10.3%
1 Month
-3.8%
-3.8%
3 Month
+8.6%
+8.6%
6 Month
+31.2%
+31.2%
1 Year
-3.5%
-3.5%
More News
Read More
What Is Considered a Good Stock Dividend? 2 Healthcare Stocks Fit the Bill.
↗
March 24, 2026
Via
The Motley Fool
Topics
Intellectual Property
Bristol-Myers Squibb Co. (NYSE:BMY): A High-Yield Dividend Stock for Income Investors
↗
March 13, 2026
Via
Chartmill
Bristol-Myers Squibb Shares Jump 3.3% on Robust 2026 Guidance and High Dividend Yield
March 23, 2026
Via
MarketMinute
Topics
Economy
Initial Public Offering
Intellectual Property
Should You Buy Bristol Myers Squibb Stock for Its 4.4%-Yielding Dividend?
↗
March 23, 2026
Via
The Motley Fool
Topics
Intellectual Property
FDA Approves Protagonist’s ICOTYDE: The Oral Peptide Revolution Hits the Psoriasis Market
March 23, 2026
Via
MarketMinute
Bristol Myers Squibb Reinforces Leadership in oHCM with New Camzyos (mavacamten) Data at American College of Cardiology Annual Scientific Session & Expo 2026 (ACC.26)
March 23, 2026
From
Bristol Myers Squibb
Via
Business Wire
1 High-Yield Dividend Stock That's Too Cheap to Ignore
↗
March 21, 2026
Via
The Motley Fool
Topics
Economy
Intellectual Property
Bristol Myers Squibb Transforms the Classical Hodgkin Lymphoma Treatment Paradigm with Expanded U.S. and EMA Approvals for Opdivo® (nivolumab)
March 20, 2026
From
Bristol Myers Squibb
Via
Business Wire
Bristol Myers Squibb to Report Results for First Quarter 2026 on April 30, 2026
March 19, 2026
From
Bristol Myers Squibb
Via
Business Wire
AbbVie Shares Retreat to Multi-Month Lows Amid Competitive Headwinds and Technical Breakdown
March 18, 2026
Via
MarketMinute
Topics
ETFs
Economy
Intellectual Property
Bristol‑Myers Squibb: The Boring Dividend Stock I'd Happily Hold Through Any Crash
↗
March 18, 2026
Via
The Motley Fool
Topics
Artificial Intelligence
Intellectual Property
READYSTATE Dumps 361,000 Workiva Shares Worth $32 Million
↗
March 17, 2026
Via
The Motley Fool
Topics
Regulatory Compliance
The Grand Divergence: Finance Surges as Health Care Braces for a Historic Q1 Earnings Slump
March 17, 2026
Via
MarketMinute
Topics
Earnings
Economy
Initial Public Offering
Merck & Co. Trades Ex-Dividend as Healthcare Emerges as a Volatility Hedge in 2026
March 16, 2026
Via
MarketMinute
Topics
Artificial Intelligence
Economy
Intellectual Property
1 ETF That Could Turn $100 Per Month Into $67,380
↗
March 15, 2026
Via
The Motley Fool
Topics
ETFs
Economy
World Trade
1 S&P 500 Stock Worth Your Attention and 2 We Question
March 12, 2026
Via
StockStory
Topics
Stocks
BioNTech Navigates Post-Pandemic Deficit: A €17 Billion Bet on the Oncology Frontier
March 10, 2026
Via
MarketMinute
3 Healthcare Stocks Paying the Highest Dividends of 2026
↗
March 10, 2026
Via
The Motley Fool
Bristol Myers Squibb Announces Positive Phase 3 Results from the SUCCESSOR-2 Study of Oral Mezigdomide in Relapsed or Refractory Multiple Myeloma
March 09, 2026
From
Bristol Myers Squibb
Via
Business Wire
Why Bristol Myers Squibb Stock Crushed it in February
↗
March 08, 2026
Via
The Motley Fool
Topics
Intellectual Property
U.S. FDA Approves Bristol Myers Squibb’s Sotyktu® (deucravacitinib) for the Treatment of Adults with Active Psoriatic Arthritis
March 06, 2026
From
Bristol Myers Squibb
Via
Business Wire
2 Top Healthcare Dividend Stocks to Buy and Hold Forever
↗
March 05, 2026
Via
The Motley Fool
Topics
Intellectual Property
Q4 Earnings Outperformers: Bristol-Myers Squibb (NYSE:BMY) And The Rest Of The Branded Pharmaceuticals Stocks
March 04, 2026
Via
StockStory
Topics
Artificial Intelligence
Intellectual Property
Frequently Asked Questions
Is Bristol-Myers Squibb publicly traded?
Yes, Bristol-Myers Squibb is publicly traded.
What exchange does Bristol-Myers Squibb trade on?
Bristol-Myers Squibb trades on the New York Stock Exchange
What is the ticker symbol for Bristol-Myers Squibb?
The ticker symbol for Bristol-Myers Squibb is BMY on the New York Stock Exchange
What is the current price of Bristol-Myers Squibb?
The current price of Bristol-Myers Squibb is 58.94
When was Bristol-Myers Squibb last traded?
The last trade of Bristol-Myers Squibb was at 03/25/26 04:10 PM ET
What is the market capitalization of Bristol-Myers Squibb?
The market capitalization of Bristol-Myers Squibb is 130.97B
How many shares of Bristol-Myers Squibb are outstanding?
Bristol-Myers Squibb has 131B shares outstanding.
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.